1.56
|
6.94e-42
|
GO:0044237
|
cellular metabolic process
|
1.70
|
2.75e-41
|
GO:0044260
|
cellular macromolecule metabolic process
|
1.47
|
1.51e-37
|
GO:0008152
|
metabolic process
|
1.52
|
1.72e-36
|
GO:0044238
|
primary metabolic process
|
1.61
|
4.86e-36
|
GO:0043170
|
macromolecule metabolic process
|
1.84
|
4.10e-35
|
GO:0006139
|
nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.77
|
4.23e-35
|
GO:0006807
|
nitrogen compound metabolic process
|
1.78
|
1.78e-34
|
GO:0034641
|
cellular nitrogen compound metabolic process
|
1.91
|
4.24e-31
|
GO:0010467
|
gene expression
|
1.88
|
4.28e-31
|
GO:0090304
|
nucleic acid metabolic process
|
1.92
|
7.44e-29
|
GO:0016070
|
RNA metabolic process
|
1.81
|
2.85e-26
|
GO:0010468
|
regulation of gene expression
|
1.74
|
3.41e-26
|
GO:0044249
|
cellular biosynthetic process
|
1.72
|
1.62e-25
|
GO:0009058
|
biosynthetic process
|
1.68
|
5.00e-25
|
GO:0060255
|
regulation of macromolecule metabolic process
|
1.82
|
5.25e-25
|
GO:2000112
|
regulation of cellular macromolecule biosynthetic process
|
1.79
|
4.54e-24
|
GO:0010556
|
regulation of macromolecule biosynthetic process
|
1.82
|
1.10e-23
|
GO:0009059
|
macromolecule biosynthetic process
|
1.82
|
1.26e-23
|
GO:0034645
|
cellular macromolecule biosynthetic process
|
1.64
|
2.24e-23
|
GO:0031323
|
regulation of cellular metabolic process
|
1.75
|
3.70e-23
|
GO:0019219
|
regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
1.82
|
3.88e-23
|
GO:0051252
|
regulation of RNA metabolic process
|
1.75
|
5.55e-23
|
GO:0051171
|
regulation of nitrogen compound metabolic process
|
1.75
|
5.80e-23
|
GO:0031326
|
regulation of cellular biosynthetic process
|
1.74
|
6.24e-23
|
GO:0009889
|
regulation of biosynthetic process
|
1.83
|
6.97e-23
|
GO:0006355
|
regulation of transcription, DNA-dependent
|
1.63
|
8.00e-23
|
GO:0080090
|
regulation of primary metabolic process
|
1.58
|
1.06e-22
|
GO:0019222
|
regulation of metabolic process
|
1.92
|
5.44e-20
|
GO:0032774
|
RNA biosynthetic process
|
1.91
|
9.65e-20
|
GO:0006351
|
transcription, DNA-dependent
|
1.71
|
6.33e-16
|
GO:0071841
|
cellular component organization or biogenesis at cellular level
|
1.56
|
4.21e-14
|
GO:0071840
|
cellular component organization or biogenesis
|
1.18
|
1.06e-13
|
GO:0009987
|
cellular process
|
1.66
|
9.88e-13
|
GO:0071842
|
cellular component organization at cellular level
|
1.82
|
2.87e-12
|
GO:0006996
|
organelle organization
|
2.00
|
6.51e-12
|
GO:0010605
|
negative regulation of macromolecule metabolic process
|
2.85
|
9.16e-12
|
GO:0016568
|
chromatin modification
|
1.99
|
1.22e-11
|
GO:0006357
|
regulation of transcription from RNA polymerase II promoter
|
1.48
|
2.70e-11
|
GO:0032502
|
developmental process
|
1.52
|
2.79e-11
|
GO:0016043
|
cellular component organization
|
1.61
|
5.42e-11
|
GO:0048523
|
negative regulation of cellular process
|
2.63
|
9.63e-11
|
GO:0006325
|
chromatin organization
|
1.49
|
1.03e-10
|
GO:0007275
|
multicellular organismal development
|
1.90
|
1.54e-10
|
GO:0009892
|
negative regulation of metabolic process
|
1.56
|
2.77e-10
|
GO:0048519
|
negative regulation of biological process
|
1.57
|
4.23e-10
|
GO:0044267
|
cellular protein metabolic process
|
2.12
|
1.00e-09
|
GO:0010629
|
negative regulation of gene expression
|
2.32
|
1.48e-09
|
GO:0051276
|
chromosome organization
|
1.50
|
1.67e-09
|
GO:0048856
|
anatomical structure development
|
1.86
|
1.31e-08
|
GO:0031324
|
negative regulation of cellular metabolic process
|
2.00
|
3.61e-08
|
GO:0010558
|
negative regulation of macromolecule biosynthetic process
|
1.50
|
3.65e-08
|
GO:0048731
|
system development
|
2.68
|
3.91e-08
|
GO:0018193
|
peptidyl-amino acid modification
|
2.08
|
4.01e-08
|
GO:0006915
|
apoptosis
|
2.02
|
4.12e-08
|
GO:2000113
|
negative regulation of cellular macromolecule biosynthetic process
|
2.02
|
4.69e-08
|
GO:0045934
|
negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
2.07
|
4.69e-08
|
GO:0012501
|
programmed cell death
|
2.21
|
4.73e-08
|
GO:0009792
|
embryo development ending in birth or egg hatching
|
2.22
|
5.82e-08
|
GO:0043009
|
chordate embryonic development
|
1.99
|
1.12e-07
|
GO:0051172
|
negative regulation of nitrogen compound metabolic process
|
1.90
|
1.76e-07
|
GO:0009790
|
embryo development
|
1.93
|
2.49e-07
|
GO:0031327
|
negative regulation of cellular biosynthetic process
|
1.96
|
3.56e-07
|
GO:0016265
|
death
|
1.91
|
4.44e-07
|
GO:0009890
|
negative regulation of biosynthetic process
|
2.02
|
4.75e-07
|
GO:0051253
|
negative regulation of RNA metabolic process
|
2.03
|
4.94e-07
|
GO:0045892
|
negative regulation of transcription, DNA-dependent
|
2.98
|
5.31e-07
|
GO:0016570
|
histone modification
|
1.56
|
5.44e-07
|
GO:0048513
|
organ development
|
1.43
|
6.61e-07
|
GO:0019538
|
protein metabolic process
|
2.93
|
8.90e-07
|
GO:0016569
|
covalent chromatin modification
|
1.56
|
9.51e-07
|
GO:0043412
|
macromolecule modification
|
1.94
|
9.81e-07
|
GO:0008219
|
cell death
|
2.08
|
1.26e-06
|
GO:0006396
|
RNA processing
|
1.84
|
2.07e-06
|
GO:0007049
|
cell cycle
|
2.41
|
4.58e-06
|
GO:0001701
|
in utero embryonic development
|
1.61
|
5.58e-06
|
GO:0009653
|
anatomical structure morphogenesis
|
3.63
|
7.12e-06
|
GO:0018205
|
peptidyl-lysine modification
|
1.54
|
8.15e-06
|
GO:0006464
|
protein modification process
|
2.73
|
2.01e-05
|
GO:0071843
|
cellular component biogenesis at cellular level
|
1.47
|
2.39e-05
|
GO:0030154
|
cell differentiation
|
2.73
|
4.81e-05
|
GO:0022613
|
ribonucleoprotein complex biogenesis
|
2.09
|
5.42e-05
|
GO:0000122
|
negative regulation of transcription from RNA polymerase II promoter
|
1.45
|
5.96e-05
|
GO:0048869
|
cellular developmental process
|
1.71
|
1.09e-04
|
GO:0009888
|
tissue development
|
3.94
|
1.86e-04
|
GO:0016573
|
histone acetylation
|
1.92
|
2.00e-04
|
GO:0048646
|
anatomical structure formation involved in morphogenesis
|
1.92
|
2.49e-04
|
GO:0072358
|
cardiovascular system development
|
1.92
|
2.49e-04
|
GO:0072359
|
circulatory system development
|
3.70
|
2.82e-04
|
GO:0050657
|
nucleic acid transport
|
3.70
|
2.82e-04
|
GO:0050658
|
RNA transport
|
3.70
|
2.82e-04
|
GO:0051236
|
establishment of RNA localization
|
3.82
|
3.15e-04
|
GO:0006475
|
internal protein amino acid acetylation
|
3.82
|
3.15e-04
|
GO:0018393
|
internal peptidyl-lysine acetylation
|
2.15
|
3.37e-04
|
GO:0051301
|
cell division
|
3.77
|
4.06e-04
|
GO:0018394
|
peptidyl-lysine acetylation
|
1.62
|
4.06e-04
|
GO:0050793
|
regulation of developmental process
|
2.97
|
4.09e-04
|
GO:0042254
|
ribosome biogenesis
|
1.66
|
4.71e-04
|
GO:0051173
|
positive regulation of nitrogen compound metabolic process
|
1.64
|
5.00e-04
|
GO:0031328
|
positive regulation of cellular biosynthetic process
|
3.56
|
5.76e-04
|
GO:0006403
|
RNA localization
|
2.25
|
6.13e-04
|
GO:0001501
|
skeletal system development
|
1.62
|
7.50e-04
|
GO:0009891
|
positive regulation of biosynthetic process
|
1.96
|
1.03e-03
|
GO:0022403
|
cell cycle phase
|
3.28
|
1.41e-03
|
GO:0015931
|
nucleobase, nucleoside, nucleotide and nucleic acid transport
|
1.69
|
1.53e-03
|
GO:0045893
|
positive regulation of transcription, DNA-dependent
|
1.69
|
1.58e-03
|
GO:0051254
|
positive regulation of RNA metabolic process
|
1.64
|
1.59e-03
|
GO:0045935
|
positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
|
3.48
|
1.68e-03
|
GO:0006473
|
protein acetylation
|
1.35
|
1.73e-03
|
GO:0048522
|
positive regulation of cellular process
|
1.59
|
2.06e-03
|
GO:0044085
|
cellular component biogenesis
|
1.76
|
2.25e-03
|
GO:0009887
|
organ morphogenesis
|
1.79
|
2.51e-03
|
GO:0022402
|
cell cycle process
|
1.53
|
2.51e-03
|
GO:0007399
|
nervous system development
|
1.79
|
2.89e-03
|
GO:0045944
|
positive regulation of transcription from RNA polymerase II promoter
|
1.52
|
3.31e-03
|
GO:0033036
|
macromolecule localization
|
1.98
|
3.60e-03
|
GO:0007389
|
pattern specification process
|
1.49
|
4.41e-03
|
GO:0031325
|
positive regulation of cellular metabolic process
|
3.54
|
4.63e-03
|
GO:0051028
|
mRNA transport
|
1.47
|
4.82e-03
|
GO:0009893
|
positive regulation of metabolic process
|
1.60
|
5.45e-03
|
GO:0010557
|
positive regulation of macromolecule biosynthetic process
|
1.62
|
5.63e-03
|
GO:0010628
|
positive regulation of gene expression
|
3.10
|
6.94e-03
|
GO:0043543
|
protein acylation
|
1.93
|
7.59e-03
|
GO:0000278
|
mitotic cell cycle
|
1.84
|
8.48e-03
|
GO:0051726
|
regulation of cell cycle
|
3.39
|
9.01e-03
|
GO:0006479
|
protein methylation
|
3.39
|
9.01e-03
|
GO:0008213
|
protein alkylation
|
2.62
|
9.16e-03
|
GO:0006913
|
nucleocytoplasmic transport
|
1.47
|
1.13e-02
|
GO:0010604
|
positive regulation of macromolecule metabolic process
|
1.41
|
1.28e-02
|
GO:0044281
|
small molecule metabolic process
|
2.56
|
1.39e-02
|
GO:0051169
|
nuclear transport
|
1.95
|
1.40e-02
|
GO:0016071
|
mRNA metabolic process
|
1.58
|
2.07e-02
|
GO:0048468
|
cell development
|
1.29
|
2.11e-02
|
GO:0048518
|
positive regulation of biological process
|
2.04
|
2.24e-02
|
GO:0006397
|
mRNA processing
|
2.45
|
2.26e-02
|
GO:0048705
|
skeletal system morphogenesis
|
2.33
|
2.36e-02
|
GO:0034470
|
ncRNA processing
|
2.05
|
2.53e-02
|
GO:0007507
|
heart development
|
2.15
|
2.80e-02
|
GO:0034660
|
ncRNA metabolic process
|
1.95
|
2.90e-02
|
GO:0035295
|
tube development
|
2.10
|
3.00e-02
|
GO:0010608
|
posttranscriptional regulation of gene expression
|
1.92
|
3.24e-02
|
GO:0000279
|
M phase
|
2.04
|
3.43e-02
|
GO:0008380
|
RNA splicing
|
2.10
|
3.71e-02
|
GO:0048514
|
blood vessel morphogenesis
|
1.54
|
4.56e-02
|
GO:2000026
|
regulation of multicellular organismal development
|
1.93
|
4.59e-02
|
GO:0001944
|
vasculature development
|